-
Etanercept, sold
under the
brand name
Enbrel among others, is a
biologic medical product that is used to
treat autoimmune diseases by
interfering with...
- and golimumab, or with a
circulating receptor fusion protein such as
etanercept.
While most
clinically useful TNF
inhibitors are
monoclonal antibodies...
- and infliximab.
Based on
studies in AS, the
results suggest infliximab,
etanercept, and
adalimumab have the
potential to
reduce the
signs and
symptoms of...
-
patient with
primary progressive aphasia utilizing off-label
perispinal etanercept, an anti-TNF
treatment strategy also used for Alzheimer's, has been reported...
- ciclosporin. Many anti-inflammatory
biological mediators, such as infliximab,
etanercept, and
anakinra are
being tried. In
January 2020, the US Food and Drug Administration...
-
against etanercept, a
biologic medication that is a
fusion protein composed of two TNF-α receptors. The lack of
neutralizing antibodies against etanercept is...
- the disease.
Infliximab as well as
other anti-TNF
therapies including etanercept and
adalimumab may be
useful in
treating mucocutaneous disease according...
-
Inhibitor treatments (infliximab, adalimumab, certolizumab, natalizumab, and
etanercept) are
thought to be the
cause of this rare disease.
Major complications...
-
caused by
treatment with
tumor necrosis factor (TNF)
inhibitors like
etanercept. The
heritability of
sarcoidosis varies according to ethnicity. About...
- survival, invasion, and metastasis. TNF-blockers such as
infliximab and
etanercept did not
induce a
response in most
advanced or
metastatic cancers, but...
